| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.68 | 0.007 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.01 |